Nonlinear Optical Detection of Peripheral Membrane Protein Interactions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack efficient and high-throughput technologies for detecting binding interactions and conformational changes of peripheral membrane proteins with membrane components, which are crucial for understanding cell signaling and membrane transport processes, and for identifying therapeutic drug candidates.
Innovation Solution
The use of nonlinear-optical detection techniques, specifically second harmonic generation (SHG), to monitor changes in peripheral membrane protein binding and conformation by labeling proteins with nonlinear-active labels and illuminating them with excitation light, allowing for surface-selective detection of binding interactions and conformational changes on supported membranes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used for peripheral membrane protein interactions, then the detection can be performed with simple equipment, but the detection sensitivity and throughput are insufficient
Solution Approach 1:
The patent replaces conventional mechanical/optical detection systems with nonlinear optical detection technology. Specifically, it uses second harmonic generation (SHG) and sum frequency generation (SFG) techniques to detect peripheral membrane protein interactions, achieving high sensitivity without requiring complex sample preparation or labeling procedures. The nonlinear optical effects directly probe the molecular interactions at the membrane interface.
Solution Approach 2:
The patent utilizes changes in nonlinear optical parameters (second harmonic intensity, sum frequency intensity) to detect binding events and conformational changes of peripheral membrane proteins. By monitoring these optical parameter changes in real-time, the system achieves high detection sensitivity and throughput simultaneously.
2Productivity
If conventional methods are used for high-throughput screening, then the equipment can be simple, but the screening efficiency and data quality are insufficient
Solution Approach 1:
The patent implements a high-throughput screening system using nonlinear optical detection that can process multiple samples simultaneously. The system maintains high detection accuracy by directly measuring molecular interactions through SHG and SFG signals, avoiding the need for complex labeling or indirect measurement methods that would reduce throughput.
Solution Approach 2:
The nonlinear optical detection system serves multiple functions: it can detect binding events, monitor conformational changes, and screen multiple compounds simultaneously. This multi-functionality enables the system to achieve high throughput while maintaining comprehensive data quality for drug candidate identification.
3Measurement precision
If labeling methods are used to enhance detection sensitivity, then the detection sensitivity improves, but the protein structure and function may be altered
Solution Approach 1:
The patent employs nonlinear optical detection methods (SHG and SFG) that do not require fluorescent or other types of labels on the proteins. The technique directly detects the optical properties of the peripheral membrane proteins themselves or uses minimal labeling that does not interfere with protein structure or function, thereby maintaining detection sensitivity while preserving protein native state.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables sensitive and high-throughput detection of peripheral membrane protein binding and conformational changes, facilitating the identification of modulating agents and providing insights into protein function and drug candidate screening.
Implementation Method 1
The use of nonlinear-optical detection techniques, specifically second harmonic generation (SHG), to monitor changes in peripheral membrane protein binding and conformation
Data Source
AI summary
Methods and devices for identifying agents that block binding or activation of peripheral membrane proteins are disclosed.